Psychopharmacology for the clinician: should we treat patients with verymild Alzheimer disease with acholinesterase inhibitor?.
Gauthier
Serge
S
McGill Centre for Studies in Aging, Douglas Mental Health University Institute Montréal, Quebec, Canada.
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000209:etiology / Q000523:psychology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D049268:Positron-Emission Tomography; D011600:Psychopharmacology; D015899:Tomography, Emission-Computed, Single-Photon
D002800:Cholinesterase Inhibitors